Himax Technologies, Inc. HIMX
10.70 USD +0.25 (+2.39%)
At closeNov 3, 2026, 5:49 PM EST
10.89 +0.19 +1.78%
After hours · Nov 3, 5:49 PM ET
10.60 Day range 10.82
6.85 52-week range 25.09
- YTD
- +30.65%
- 1 year
- +15.05%
Analyst view
Price target (mean) 30.20 +182.2% upside
Now 10.70
- Target (low)
- 17.40
- Target (mean)
- 30.20
- Target (high)
- 43.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09 | 0.09 – 0.09 | 0.006 | +1400.0% | 247.76M | +24.4% | 1 |
| Next quarter | 0.22 | 0.22 – 0.22 | 0.036 | +511.1% | 272.66M | +34.3% | 1 |
| Current year | 0.47 | 0.47 – 0.47 | 0.252 | +86.5% | 949.39M | +14.1% | 1 |
| Next year | 1.30 | 1.30 – 1.30 | 0.47 | +176.6% | 1.23B | +29.6% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Baird | Maintained | Outperform | Outperform |
| Aug 11, 2023 | Credit Suisse | Upgrade | Neutral | Outperform |
| Jul 14, 2022 | Credit Suisse | Downgrade | Outperform | Neutral |
| May 16, 2022 | Credit Suisse | Maintained | — | Outperform |
| Apr 7, 2022 | Nomura Instinet | Downgrade | Buy | Neutral |
| Sep 17, 2021 | Vertical Research | Downgrade | Hold | Sell |
| Jan 31, 2020 | Lake Street | Upgrade | Hold | Buy |
| Jan 6, 2020 | Credit Suisse | Upgrade | Underperform | Neutral |
| Jul 12, 2019 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 20, 2018 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 9, 2018 | Credit Suisse | Downgrade | Outperform | Neutral |
| Oct 1, 2018 | Roth Capital | Upgrade | Neutral | Buy |
| Aug 16, 2018 | Macquarie | Downgrade | Outperform | Neutral |
| Mar 15, 2018 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 27, 2017 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 10, 2017 | Baird | Maintained | — | Outperform |
| Oct 11, 2017 | Mizuho | Downgrade | Buy | Neutral |
| Sep 28, 2017 | Lake Street | Upgrade | Hold | Buy |
| Aug 4, 2017 | Baird | Upgrade | Neutral | Outperform |
| Jul 14, 2017 | Oppenheimer | Downgrade | Perform | Underperform |
| Mar 10, 2017 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Mar 9, 2017 | Mizuho | Upgrade | Neutral | Buy |
| Feb 16, 2017 | Northland Capital Markets | Upgrade | Market Perform | Outperform |
| Feb 7, 2017 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Jan 30, 2017 | Baird | Downgrade | Outperform | Neutral |
| Jan 11, 2017 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 7, 2016 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Sep 29, 2016 | Roth Capital | Initiated | — | Buy |
| Sep 26, 2016 | Nomura | Downgrade | Buy | Neutral |
| Jul 5, 2016 | Nomura | Upgrade | Neutral | Buy |